Goodbody Health Ltd - Director/PDMR Shareholding
RNS Number : 6336X
Goodbody Health Limited
30 August 2022
 

30th August 2022

Goodbody Health Limited.
("Goodbody Health", or the "Company")

 

Director Transfer of Ordinary Shares

 

The Company today announces that Geremy Thomas, the Executive Chairman and Director of the Company transferred 200,000 ordinary shares to an unrelated party for nil consideration on August the 30th 2022. Post this transaction Geremy Thomas has an interest in 7,640,638 ordinary shares, representing approximately 20.94% of the issued share capital of the Company.

The directors of the Company accept responsibility for the contents of this announcement.

For further information:

Marc Howells

Chief Executive Officer

Goodbody Health Limited.

+44 (0) 20 7971 1255

enquiries@goodbodyhealth.com

 www.goodbodyhealth.com

Anne Tew

Chief Financial Officer

Goodbody Health Limited.

+44 (0) 20 7971 1255

enquiries@goodbodyhealth.com

 www.goodbodyhealth.com

 


 

AQSE Corporate Adviser

Peterhouse Capital Limited

Guy Miller/Mark Anwyl

+44 (0) 20 7469 0930

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Geremy Thomas

2

Reason for the notification

a/)

Position/status

Executive Chairman

/b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 Goodbody Health Limited

b)

LEI

213800V7NVQZF5G8VS50

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares

 

ISIN: GG00BP6KMG85

b)

Nature of the transaction

Transfer of shares to a third party

c)

Price(s) and volume(s)

200,000 ordinary shares for nil consideration

d)

Aggregated information

- Aggregated volume

- Price

 

 

e)

Date of the transaction

30 August 2022

f)

Place of the transaction

AQSE

 

 



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXBXGDICUXDGDG ]]>